Thrombin Receptor (TR) ELISA Kit
Species reactivity
Human (Homo sapiens)
Recognized antigen
Thrombin Receptor (TR)
Product type
Immunoassays, ELISA kits
Long Name
Human Thrombin Receptor (TR) ELISA Kit
Test
ELISA Enzyme-linked immunosorbent assays Code 90320007 SNOMED
Properties
E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays,E05 478 566 350 170 or Enzyme-Linked Immunosorbent Assays
Laboratory tips
Small volumes from the liquid components of the Thrombin Receptor (TR) EIA kit may get caught on the walls and lid of the vials. Prior to use, briefly centrifuge the vial to ensure that all of the content is gathered on the bottom.
Description
The Human Thrombin Receptor (TR) ELISA Kit is a ready to use kit manufactured by using high quality antibodies sets, plates, solutions and detection molecules. This EIA test for Human Thrombin Receptor (TR) will yield accurate and reproducible results. The specially designed buffers ensure the most suitable conditions for the detection reactions.
Storage conditions
Store all components and reagents of the Thrombin Receptor (TR) ELISA Kit refrigerated and +4 degrees Celcius. For a long term storage the kit's components may be frozen at -20 but cycles of freezing and thawing should be strictly avoided as they denaturate the polypeptide chains in the antibodies and controlls, thus causing a reduction in the kit's detection ability and specificity which changes will lead to inconsistant results.
Additional description
The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.